Related references
Note: Only part of the references are listed.Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
Gustavo Luna et al.
JAMA NEUROLOGY (2020)
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Alexander Duscha et al.
CELL (2020)
Hookworm Treatment for Relapsing Multiple Sclerosis
Radu Tanasescu et al.
JAMA Neurology (2020)
Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs
Judith Wienke et al.
JCI INSIGHT (2020)
Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance
Simon Glatigny et al.
JOURNAL OF IMMUNOLOGY (2019)
Conversion of antigen-specific effector/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8/19
Masahiko Akamatsu et al.
SCIENCE IMMUNOLOGY (2019)
Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis
Samuel S. Duffy et al.
JOURNAL OF NEUROSCIENCE (2019)
Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
Minako Ito et al.
NATURE (2019)
TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
Heonjong Han et al.
NUCLEIC ACIDS RESEARCH (2018)
Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1-derived peptide recombinant protein tyrosine phosphatase (AP-rPTP), alleviates both atopic dermatitis-like and psoriasis-like dermatitis
Won-Ju Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
Eleonora Trotta et al.
NATURE MEDICINE (2018)
Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
Jiatao Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human Check for skin and microvessel graft rejection
Sangho Lim et al.
BIOMATERIALS (2018)
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis
Samia J. Khoury et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis
Samia J. Khoury et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis
Sorcha Mildiner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Generation of RORγt+ Antigen-Specific T Regulatory 17 Cells from Foxp3+ Precursors in Autoimmunity
Byung-Seok Kim et al.
CELL REPORTS (2017)
IL-17A-Producing Foxp3+ Regulatory T Cells and Human Diseases
Min Kyung Jung et al.
IMMUNE NETWORK (2017)
Protein kinase C-eta regulates Mcl-1 level via ERK1
Deepanwita Pal et al.
CELLULAR SIGNALLING (2017)
dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses
Sangho Lim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells
Jing Geng et al.
NATURE IMMUNOLOGY (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B. Canavan et al.
GUT (2016)
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis
Kimitoshi Kimura et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells
Ajithkumar Vasanthakumar et al.
NATURE IMMUNOLOGY (2015)
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
Sangho Lim et al.
NATURE COMMUNICATIONS (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Protein kinase C-η controls CTLA-4-mediated regulatory T cell function
Kok-Fai Kong et al.
NATURE IMMUNOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Jennifer Pieper et al.
BMC IMMUNOLOGY (2013)
The B7-Independent Isoform of CTLA-4 Functions To Regulate Autoimmune Diabetes
Melanie Stumpf et al.
JOURNAL OF IMMUNOLOGY (2013)
Secondary autoimmune diseases following alemtuzumab therapy for multiple sclerosis
Lisa Costelloe et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Phosphatases in SMAD regulation
David L. Bruce et al.
FEBS LETTERS (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling
Chris Hough et al.
PLOS ONE (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
Ashutosh Chaudhry et al.
IMMUNITY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease
Margarita Dominguez-Villar et al.
NATURE MEDICINE (2011)
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
P. W. O'Connor et al.
NEUROLOGY (2011)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
Complement in multiple sclerosis: its role in disease and potential as a biomarker
G. Ingram et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The Treg/Th17 Cell Balance: A New Paradigm for Autoimmunity
Eli M. Eisenstein et al.
PEDIATRIC RESEARCH (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
CTLA4Ig treatment in patients with multiple sclerosis - An open-label, phase 1 clinical trial
V. Viglietta et al.
NEUROLOGY (2008)
Effects of Natalizumab Treatment on Foxp3+T Regulatory Cells
Max-Philipp Stenner et al.
PLOS ONE (2008)
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
Satoshi Serada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis
Je-Min Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
The protein kinase C-η isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway
R. M. Uht et al.
ONCOGENE (2007)
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
Yisong Y. Wan et al.
NATURE (2007)
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent
J Kearley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3
I Matsuura et al.
BIOCHEMISTRY (2005)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
B7-independent inhibition of T cells by CTLA-4
S Chikuma et al.
JOURNAL OF IMMUNOLOGY (2005)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
TGF-β induces Foxp3+T-regulatory cells from CD4+CD25-precursors
S Fu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Interleukin-2 is essential for CD4+CD25+ regulatory T cell function
M de la Rosa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
QZ Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes
KV Tarbell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells
L Vijayakrishnan et al.
IMMUNITY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Protein kinase C (PKC) η-mediated PKCμ activation modulates ERK and JNK signal pathways
I Brändlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
E Chuang et al.
IMMUNITY (2000)
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
T Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
